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After 10 years of absence, dengue virus type 4 (DENV-
4) has recently reemerged in Martinique, Guadeloupe, and
French Guiana. Phylogenetic analyses of strains isolated
from 2004 to 2005 showed that they belong to DENV-4
genotype II, but to a different cluster than strains isolated
from 1993 to 1995.
D
engue is a viral disease transmitted by mosquitoes. It
is caused by any of the 4 viral serotypes of dengue
virus (DENV), designated DENV-1, DENV-2, DENV-3,
and DENV-4. DENV belongs to the genus Flavivirus and
family  Flaviviridae. Flaviviruses are enveloped, single-
stranded, positive-sense RNA viruses. The genomic RNA
is ≈11 kb and has 10 genes coding 3 structural proteins
(capsid [C], envelope [E], and membrane [M]), and 7 non-
structural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b,
and NS5).
Dengue is the predominant arthropodborne viral dis-
ease affecting humans. DENV causes a wide range of
symptoms from inapparent or mild disease (dengue fever)
to severe forms such as dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS). The disease is now
endemic in >100 countries and threatens >2.5 billion peo-
ple. It currently occurs in tropical areas and affects <100
million persons each year (1). Of these persons, 500,000
have DHF and ≈25,000, mainly children, die. The World
Health Organization has estimated a 30-fold incidence
increase in dengue the past 50 years (2).
DENV is transmitted to humans by Stegomyia aegypti
(formerly Aedes aegypti) mosquitoes. Before the 1980s,
epidemic dengue was rare in the Americas because St.
aegypti had been eradicated from most Central and South
American countries. In the 1990s, St. aegypti had almost
completely reinvaded the regions in which it was found
before its eradication. Within the past 30 years, the
increase in the worldwide transportation network, as well
as uncontrolled population growth and urbanization, has
led to larger and more frequent DENV epidemics and more
cases of DHF/DSS (3).
During the past 20 years, the 4 DENV serotypes have
been isolated in the French departments of the Americas:
Guadeloupe, Martinique, and French Guiana. Martinique
and Guadeloupe are 2 Caribbean islands located in the
Lesser Antilles and represent the French West Indies, and
French Guiana is located southeast of the French West
Indies in northern South America between Suriname and
Brazil. DENV is endemic in French Guiana. Dengue epi-
demics occurred in this country at 4–6-year intervals from
the 1960s to the early 1990s (4). The first DHF cases were
associated with a DENV-2 outbreak in 1991–1992 (5).
DENV-4 was sporadically isolated between 1993 and
1995. Cocirculation of DENV-1 and DENV-2 caused out-
breaks between 1996 and 1998, followed by 2 consecutive
DENV-3 epidemics in 2001–2002 and 2004–2005.
Martinique had 3 dengue epidemics during the past decade
in a setting of sporadic transmission and seasonal peaks
from July to December. These epidemics were associated
with DENV-2 and DENV-4 in 1995, DENV-1 in 1997, and
DENV-3 in 2001 (6). The epidemiology of DENV in
Guadeloupe is similar to that in Martinique, although no
data are available about previous dengue epidemics.
The Study
Our study reports the evolution of DENV-4 in French
Guiana and the French Caribbean islands since its last
detection and circulation from 1993 to 1995. We studied 8
DENV-4 strains isolated from human sera from French
Guiana in 1993 and 1995 (n = 6) and in 2004 and 2005
(n = 2) (Table). We also tested 3 human serum specimens
from Martinique (n = 2) and Guadeloupe (n = 1) that were
positive for DENV-4 during dengue surveillance in the
fourth quarter of 2004. 
DENV-4 infection was confirmed by using virus isola-
tion on AP 61 cells as previously described (7). We then
amplified from first-passage RNAa 1,940-bp region of the
genome for the E gene and adjacent prM/M and NS1 junc-
tions previously described (8) to analyze the phylogenetic
relationships of these strains. Each PCR product was
cloned by using the TOPO TA Cloning kit (Invitrogen,
Paisley, UK). For each isolate, 3 clones were sequenced by
Genome Express (Meylan, France).
We compared our 11 sequences to the 87 DENV-4
sequences available in the GenBank database. Sequences
were aligned by using MacVector version 7.2 software
(Oxford Molecular Ltd., Oxford, UK). Percentage of
nucleotide identity between sequences was determined for
all observed differences (including insertions and deletions)
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sequences analyzed. Sequence comparison of strains from
Martinique, Guadeloupe, and French Guiana with those
reported from Asia showed that nucleotide divergence is
8%–12%. The level of nucleotide divergence was lower
for sequences from the Caribbean area (maximum
nucleotide divergence 2.8%). All 11 newly obtained
sequences were different from each other. These sequences
exhibited a 0.06%–0.47% nucleotide divergence (strains
isolated in 1993 and 1995) and a 0.06%–1.22% nucleotide
divergence (strains isolated in 2004 and 2005) among
themselves. These strains had amino acid changes at posi-
tion 351 in the E gene (from isoleucine to valine) and posi-
tion 52 in the NS1 gene (from lysine to arginine), which
supports their inclusion in the modern Caribbean basin
clade (8).
We conducted phylogenetic analyses on nucleotide
sequences by using distance and parsimony methods in
PAUP* version 4.0b8 to increase the reliability of derived
tree topologies (9). We also used the neighbor-joining dis-
tance matrix algorithm with the Kimura 2 parameter
(Figure) and the heuristic algorithm for the maximum par-
simony analysis (data not shown). Robustness of resulting
topologies was examined by using bootstrap analyses (10).
Both neighbor-joining and parsimony algorithms under-
went 1,000 iterations.
The phylogenetic tree constructed with the neighbor-
joining method on nucleotide sequences restricted to all
American DENV-4 isolates available in GenBank (Table)
is shown in the Figure. Our 11 strains segregate into 2
main clades that were identified in the 2 phylogenetic
analyses from consistent topologic associations and high
bootstrap values. The strains isolated from French Guiana
in 1993 and 1994 clustered with strains from Suriname and
Costa Rica, which were isolated at the same time, as well
as with a previously reported strain from Martinique isolat-
ed in 1995. Our 5 strains isolated in 2004 and 2005 are
related to a group of DENV-4 genotype II sequences
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strains circulating in French departments of the Americas
in 2004 and 2005 probably evolved from strains detected
in the Caribbean islands during the late 1990s. Our obser-
vations confirm that DENV-4 lineages in the Caribbean
and nearby regions are grouped temporally rather than by
the geographic origin of the isolates, as has been previous-
ly suggested (8).
Conclusions
The DEN-4 serotype was first reported in the Americas
in 1981. At that time, isolates collected in the Americas
were similar to strains collected in Southeast Asia. This lin-
eage was designated DENV-4 genotype II (11). Since it was
first detected in Dominica and the French islands of Saint
Barthelemy and Saint Martin (12), this genotype has spread
rapidly throughout the Caribbean and Latin America and
caused DF and sporadic cases of DHF/DSS (3).
DENV-4 genotype II never stopped circulating in the
Caribbean region, despite its being periodically locally
eliminated (8). This genotype reappeared in French depart-
ments of the Americas in 2004 after the introduction of a
strain circulating in neighboring Caribbean islands, rather
than by reemergence of a strain detected 10 years ago.
Furthermore, this DENV-4 genotype was detected in French
Guiana (October 2004) a few weeks after it was detected in
Martinique (August 2004), which suggests that the strain
came from the Antilles (Table). A similar phenomenon had
already been observed in 1999 for the DENV-3 genotype (J.
Morvan, unpub. data). This model of viral spread may be
caused by cultural and economic ties between French
departments, which allows gene flow through the
Caribbean islands and South America as persons with
viremia move through the region. This reflects the general
pattern of dengue evolution in the Americas (13,14).
Reintroduction of DENV-4 in the French Antilles and
French Guiana in 2004 after a decade of absence highlights
the risk for subsequent epidemics in persons with no
immunity to dengue. As expected, the French Antilles had
a major DENV-4 epidemic with cocirculation of DENV-2
from July 2005 to January 2006 (15). In contrast, only spo-
radic cases of DENV-4 infection have been observed in
French Guiana since the beginning of 2005. This indicates
that other factors such as mosquito density or human sus-
ceptibility, in addition to immune status of the host or
silent transmission of the virus, can modulate the risk for
dengue epidemics.
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